RecruitingHeart FailureHeart Failure - NYHA II - IV
Evaluation of Liver Stiffness Performance, by FibroScan®, to Detect Elevated Central Venous Pressure (CVP)
Eligible age
18+ yrs
Accepts
All genders
Locations
4 states
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
This is a pivotal, global, prospective, cross-sectional, multicentric clinical investigation designed to explore a non-invasive, reliable alternative to invasive, catheter-based hemodynamic assessments, which are associated with procedural risks and limited applicability in certain participant populations.
Sponsor: Echosens
You may qualify if…
- ✓ 1. Have read, understood, and signed the informed consent form (ICF)
- ✓ 2. Be ≥18 years of age at the time of screening
- ✓ 3. Have suspected or diagnosed acute or chronic HF and be scheduled to undergo right-sided cardiac catheterization
You may not qualify if…
- ✕ 1. Inability to consent
- ✕ 2. Chronic liver disease (self-reported alcohol use \>14 drinks/week in females and \>21 drinks/week in males), positive hepatitis C virus serology, positive hepatitis B surface antigen, autoimmune hepatitis, hemochromatosis, or cholestatic disease)
- ✕ 3. BMI \>40 kg/m2
- ✕ 4. Fontan-type circulation
- ✕ 5. Ascites
- ✕ 6. Heart transplantation
- ✕ 7. Pregnancy, breastfeeding, or intent to become pregnant during the study
- ✕ 8. Intent to donate/bank or retrieve eggs (ova, oocytes) or donate sperm during the study
Where it's recruiting
Source: ClinicalTrials.gov · NCT07222813 · last updated 2026-09-23